Icosavax (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 03, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $51,000,000
Company Info
- Company Description
- Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.
- Market
- Infectious Diseases
- Location
- Seattle, WA, USA
- Coinvestors
- Adams Street Partners, NanoDimension, Qiming Venture Partners, Sanofi Ventures